— Know what they know.
Not Investment Advice

ARVN NASDAQ

Arvinas, Inc.
1W: -3.4% 1M: -14.4% 3M: -24.1% YTD: -20.7% 1Y: +37.0% 3Y: -61.0% 5Y: -86.4%
$9.09
-0.01 (-0.11%)
 
Weekly Expected Move ±6.0%
$8 $9 $9 $10 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 29 · $586.5M mcap · 56M float · 1.65% daily turnover · Short 38% of daily vol

Cash Flow Trends

Operating Cash Flow
-$274M -5.6% ▼
Capital Expenditures
$2M -5.6% ▼
5Y CAGR: -21.7%
Free Cash Flow
-$276M -5.6% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$92M +0.0% ▲
Net Change in Cash
$42M +119.6% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$191M-$282M-$367M-$199M-$81M
Depreciation & Amort.$6M$8M$7M$7M$5M
Stock-Based Comp.$57M$76M$72M$88M$44M
Change in Working Capital$678M-$83M-$44M-$141M-$234M
Other Non-Cash Items$9M$8M-$14M-$15M-$8M
Operating Cash Flow$559M-$274M-$348M-$259M-$274M
— Investing Activities —
Capital Expenditures-$5M-$7M-$3M-$2M-$2M
Acquisitions (Net)$0$400K$0$100K$0
Investment Purchases-$1.7B-$886M-$956M-$652M-$354M
Investment Sales$436M$1.1B$1.2B$688M$764M
Other Investing$0-$400K$0$0$0
Investing Cash Flow-$1.3B$243M$204M$35M$408M
— Financing Activities —
Net Debt Issuance$0$0$0-$400K-$200K
Stock Repurchased$0$0$0$0-$92M
Dividends Paid$0$0$0$0$0
Other Financing$14M$0$0$0$0
Financing Cash Flow$279M$5M$375M$8M-$91M
Net Change in Cash-$476M-$26M$230M-$217M$42M
Cash End of Period$113M$87M$317M$100M$143M
Free Cash Flow$555M-$280M-$351M-$261M-$276M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms